中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
合肥物质科学研究院 [17]
地理科学与资源研究所 [2]
化学研究所 [2]
上海药物研究所 [1]
上海有机化学研究所 [1]
武汉物理与数学研究所 [1]
更多
采集方式
OAI收割 [25]
内容类型
期刊论文 [23]
EI期刊论文 [2]
发表日期
2024 [1]
2022 [9]
2021 [5]
2020 [3]
2014 [5]
2008 [2]
更多
学科主题
天文学 [1]
天文学:太阳与太阳系 [1]
生命有机化学 [1]
筛选
浏览/检索结果:
共25条,第1-10条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
题名升序
题名降序
提交时间升序
提交时间降序
作者升序
作者降序
发表日期升序
发表日期降序
Persistent Upflows and Downflows at Active Region Boundaries Observed by SUTRI and AIA
期刊论文
OAI收割
ASTROPHYSICAL JOURNAL, 2024, 卷号: 965, 期号: 2
作者:
Wu, Yuchuan
;
Hou, Zhenyong
;
Li, Wenxian
;
Bai, Xianyong
;
Song, Yongliang
  |  
收藏
  |  
浏览/下载:21/0
  |  
提交时间:2024/04/22
Analysis of the efficacy and safety of immunotherapy in advanced thymoma patients
期刊论文
OAI收割
CANCER MEDICINE, 2022
作者:
Hao, Yue
;
Lin, Gen
;
Xiang, Jing
;
Wang, Wenxian
;
Xu, Chunwei
  |  
收藏
  |  
浏览/下载:31/0
  |  
提交时间:2022/12/23
efficacy
immune-related adverse events
immunotherapy
thymoma
Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor
期刊论文
OAI收割
THORACIC CANCER, 2022
作者:
Wang, Wenxian
;
Wang, Qian
;
Xu, Chunwei
;
Li, Ziming
;
Song, Zhengbo
  |  
收藏
  |  
浏览/下载:58/0
  |  
提交时间:2022/12/23
checkpoint inhibitor pneumonitis
Chinese experts consensus
immune checkpoint inhibitor-related adverse effects
Baseline anemia predicts a poor prognosis in patients with non-small cell lung cancer with epidermal growth factor receptor mutations: a retrospective study
期刊论文
OAI收割
BMC PULMONARY MEDICINE, 2022, 卷号: 22
作者:
Wei, Jingwen
;
Xiang, Jing
;
Hao, Yue
;
Si, Jinfei
;
Wang, Wenxian
  |  
收藏
  |  
浏览/下载:42/0
  |  
提交时间:2022/12/22
Anemia
Epidermal growth factor receptor
Epidermal growth factor receptor tyrosine kinase inhibitors
Non-small cell lung cancer
Treatment outcomes and prognosis of immune checkpoint inhibitors therapy in patients with advanced thymic carcinoma: A multicentre retrospective study
期刊论文
OAI收割
EUROPEAN JOURNAL OF CANCER, 2022, 卷号: 174
作者:
Wang, Wenxian
;
Lin, Gen
;
Guan, Yelan
;
Zhang, Yuxin
;
Xu, Chunwei
  |  
收藏
  |  
浏览/下载:43/0
  |  
提交时间:2022/12/23
Thymic carcinoma
Immunotherapy
PD-1
Efficacy
Immune-related adverse events
Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China
期刊论文
OAI收割
THORACIC CANCER, 2022
作者:
Xu, Chunwei
;
Si, Lu
;
Wang, Wenxian
;
Li, Ziming
;
Song, Zhengbo
  |  
收藏
  |  
浏览/下载:66/0
  |  
提交时间:2022/12/22
fusion
precision medicine
solid tumor
targeted therapy
tyrosine receptor kinase
Apatinib in patients with recurrent or metastatic thymic epithelial tumor: a single-arm, multicenter, open-label, phase II trial
期刊论文
OAI收割
BMC MEDICINE, 2022, 卷号: 20
作者:
Song, Zhengbo
;
Lou, Guangyuan
;
Wang, Yina
;
Yang, Zhiping
;
Wang, Wenxian
  |  
收藏
  |  
浏览/下载:49/0
  |  
提交时间:2022/12/23
Thymic epithelial tumors
Apatinib
Efficacy
Toxicities
Efficacy and safety of anlotinib with and without EGFR-TKIs or immunotherapy in the treatment of elder patients with non-small-cell lung cancer: a retrospective study
期刊论文
OAI收割
BMC PULMONARY MEDICINE, 2022, 卷号: 22
作者:
Wang, Wenxian
;
Shao, Lan
;
Xu, Yibing
;
Song, Zhengbo
;
Lou, Guangyuan
  |  
收藏
  |  
浏览/下载:45/0
  |  
提交时间:2022/12/23
Non-small cell lung cancer
Prognosis
Angiogenesis
Tyrosine kinase inhibitors
Treatment outcomes and prognosis of patients with primary and acquired BRAF-mutated non-small cell lung cancer: A multicenter retrospective study
期刊论文
OAI收割
GENES CHROMOSOMES & CANCER, 2022
作者:
Wang, Wenxian
;
Gu, Xiaodong
;
Si, Jinfei
;
Pu, Xingxiang
;
Wang, Liping
  |  
收藏
  |  
浏览/下载:88/0
  |  
提交时间:2022/05/16
BRAF mutation
immune checkpoint inhibitors
non-small cell lung cancer
PD-L1
targeted therapy
Disease progression patterns and molecular resistance mechanisms to crizotinib of lung adenocarcinoma harboring ROS1 rearrangements
期刊论文
OAI收割
NPJ PRECISION ONCOLOGY, 2022, 卷号: 6
作者:
Zhang, Yongchang
;
Huang, Zhe
;
Zeng, Liang
;
Zhang, Xiangyu
;
Li, Yizhi
  |  
收藏
  |  
浏览/下载:59/0
  |  
提交时间:2022/05/05